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Abstract
Background: Understanding relationships between substance use and suicidal ideation and behaviour (SIB) has
important public health implications for suicide prevention in low- and middle-income countries (LMICs), where
75% of suicides occur. This systematic review explored the associations between substance use and SIB in LMICs.
Methods: We searched five databases using a combination of keywords for substance use, SIB and LMICs to identify
English-written quantitative studies published between January 2006 and February 2016. Data were extracted to provide
an overview of what is known about the topic, highlight gaps in the literature, and explore the implications of current
knowledge for suicide prevention. Studies included in the review were assessed for methodological quality using the
Scottish Intercollegiate Guidelines Network checklist.
Results: Analysis of included studies (N = 108) demonstrated a consistent positive association between substance use
and SIB across all substances (i.e. alcohol, tobacco, cannabis, illicit drugs, non-medical use of prescription drugs), all
substance use dimensions (i.e. intoxication, use, and pathological use) and all SIB dimensions (i.e. suicidal ideation, non-
fatal suicidal behaviour, and suicide). Most of the available research evidence comes from upper-middle-income
countries, only 22% comes from lower-middle-income and low-income countries. Most studies focused on
alcohol and tobacco, while neglecting substances such as cannabis, opioids, sedatives, stimulants, misuse of
prescription medication, inhalants, and hallucinogens. Most of the studies employed a cross-sectional design,
were conducted within a risk-factor paradigm, and provided little information about the potential interaction
between variables.
Conclusions: Public health suicide prevention policy and research in LMICs should take account of the fact
that: substance use is a potentially modifiable risk factor; assessment and management of substance use is
integral to the care of at-risk patients; reducing consumption and hazardous use of substances in LMICs is
important for suicide prevention; and research needs to be expanded to include more theory driven research
that focuses on all substance use dimensions and SIB dimensions, while employing more sophisticated
statistical methods.
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Background
Suicide prevention, particularly in low- and middle-
income countries (LMICs), is a serious public health
challenge. Suicide is the 15th leading cause of death
worldwide, with more than 800,000 people dying by sui-
cide each year [1]. Seventy-five percent of suicides occur
in LMICs, where the estimated age-standardized suicide
rate is 11·2 per 100,000 people and the male-to-female
ratio is 1·6:1 [1]. Research from high-income countries
(HICs) suggests that substance use is a potentially modi-
fiable risk factor for suicide [1]. Global action plans and
strategies endorsed by the World Health Assembly con-
sider substance use a priority area for global action in
preventing suicide. The World Health Organization
(WHO) Mental Health Action Plan 2013 to 2020 aims
to reduce suicide rates by 10% across countries [2]. It
has been proposed that suicide prevention efforts should
focus on the full range of suicidal phenomena, including
suicidal ideation and non-fatal suicidal behaviour [1]. It
is within this context that we set out to conduct a sys-
tematic review of literature published in English report-
ing on the relationships between substance use and
suicidal ideation and behaviour in LMICs. We provide a
synthesis of the research in this area and highlight gaps
in the literature. The findings of this systematic review
will be of interest to public health policy makers and re-
searchers who are concerned about suicide prevention
in LMICs.
For the purpose of this review, suicidal ideation refers
to any thoughts of death, intention to kill oneself, or
plan to end one’s life. Non-fatal suicidal behaviour is
understood as intentional self-injurious behaviour that is
non-habitual and with a non-fatal outcome [1, 3]. Sui-
cide refers to the act of deliberately killing oneself [1],
and is synonymous with fatal suicidal behaviour. The
term suicidal ideation and behaviour (SIB) is used to de-
note the full spectrum of suicidal phenomena, including
suicidal ideation, non-fatal suicidal behaviour and
suicide.
Globally, harmful alcohol use is implicated in an esti-
mated 3·3 million deaths annually (5·9% of all deaths)
and contributes to approximately 4·6% of disability-
adjusted life years [4, 5]. Rates of deaths attributable to
alcohol are almost double among males (7·6%) when
compared with females (4%) worldwide [5]. Illicit drug
use also constitutes a significant risk to the global bur-
den of disease and disability. Approximately one out of
every 20 people aged 15 to 64 years old reported illicit
drug use at least once during 2013, where the substances
used were commonly cannabis, opioids, cocaine and am-
phetamines [6]. A mortality rate of 40·8 drug-related
deaths per million people aged 15 to 64 years old was re-
ported in 2013, with drug overdose being the most com-
mon cause of death [6]. Across all drug types, it is
estimated that roughly two thirds of the years of life lost
and lived with disability are attributed to men [6]. Harm-
ful alcohol use and illicit drug use estimates in LMICs
vary greatly across settings and the available information
is limited by inadequate national registries in these
countries [5]. For example, 40% of the alcohol consumed
in low-income countries (LICs) is unrecorded [1].
It is well established that SIB is associated with psy-
chopathology, principally depressive disorders, bipolar
mood disorders, personality disorders and psychotic ill-
nesses [7, 8]. However, substance use and substance use
disorders are also clearly associated with increased risk
of SIB. For example, alcohol plays a role in every fifth
suicide [5], while tobacco and illicit drug use (e.g. canna-
bis and heroin) have been positively associated with SIB
[9]. The current evidence base for the association be-
tween substance use and SIB comes predominantly from
research conducted in HICs [10]. In recent years, the as-
sociation between substance use and SIB in LMICs has
received increasing attention [1].
A number of hypotheses and theories have been ad-
vanced in an effort to explain the links between substance
use and SIB. Biological theories postulate that substance
use (e.g. acute intoxication that increases impulsivity or
disinhibition and impairs judgement and problem-solving
abilities) represents a vulnerability or predisposition (di-
athesis) to SIB. Within this model, stressful events (e.g. a
depressive episode or relationship conflict) act as triggers
which can lead to SIB [11]. The sociological theory of SIB
suggests that the risk for SIB is inversely associated with
the degree of social integration or regulation [12]. Prob-
lematic substance use may hold destructive consequences
for social integration and disturb social regulation, which
in turn leads to SIB [11]. Interpersonal theory builds on
this premise by postulating that suicide risk results from
the simultaneous experience of a low sense of belonging-
ness or connectedness, perceived burdensomeness and
the capability to engage in SIB [13, 14]. Social epidemio-
logical theories posit that an individual’s risk for suicide
depends not only on their personal experiences, but also
on the interplay between cultural, economic, social and
environmental factors [15, 16].
While research on the association between substance
use and SIB is receiving increased attention in many
HICs, the topic has been rather absent from research
conducted in LMICs. What is true in one context can-
not simply be accepted to be true in another setting. As
such, suicide prevention in LMICs may not be appropri-
ate if it is based on models employed in HICs that are
not challenged by poverty and have greater government
involvement in issues related to substance use and SIB.
Therefore, context specific research is imperative if we
aim to develop and implement effective suicide preven-
tion interventions in LMICs. No systematic review has
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explored the association between substance use and SIB
in LMICs. Previous reviews have established an associ-
ation between alcohol [11, 17–23], tobacco [24], or illicit
drug [17, 21, 22, 25] use and SIB dimensions, yet none
have focused on all substance types and a full range of
SIB across all LMICs. It is within this context that we in-
vestigate: (a) what is known about the ways in which
substance use is associated with SIB in LMICs; (b) what
remains unknown about the ways in which substance
use is associated with SIB in LMICs; and (c) where re-
searchers should focus their attention with regards to
the ways in which substance use is implicated in SIB in
LMICs.
Methods
Search strategies
A comprehensive search strategy was developed in ac-
cordance with the Preferred Reporting Items for System-
atic Reviews and Meta-Analyses checklist (PRISMA).
We searched: PubMed/MEDLINE, CINHAL Plus
(EBSCO), DARE (Database of Abstracts of Reviews of
Effectiveness), Web of Science and PsycINFO (OvidSP)
databases. A search strategy was designed for PubMed
that combined keywords for SIB, substances, and
LMICs. This strategy was then adapted for each subse-
quent database (Additional file 1: Appendix A).
We searched for studies with titles and abstracts pub-
lished in English between 1 January 2006 and 10 Febru-
ary 2016. We limited our search to this period because
an initial mapping exercise demonstrated that prior to
2006 there were few studies in LMICs that included ro-
bust methodologies investigating the association be-
tween substances and SIB. Reference lists of all included
review articles were searched for relevant publications
that had not been included after searching the databases.
Search terms
We included all substances and all substance use dimen-
sions (i.e. use, misuse, intoxication, withdrawal) identified
in the substance-related and addictive disorders chapter of
the Diagnostic and Statistical Manual of Mental Disorders
(DSM) 4th edition [26] and 5th edition [27]. We excluded
studies that did not distinguish between illicit and pre-
scribed drugs. Considering the classification of SIB used
by the WHO in 2014 [1], this review included a broad
range of search terms for SIB, including suicidal thoughts/
ideation, suicide plan, self-harm, attempted suicide, and
suicide. Studies related to violence, terrorism and assisted
suicide were not included in this review. Search terms
used to capture studies from LMICs included all the indi-
vidual countries on the list of LMICs from the World
Bank in 2016 (Additional file 1: Appendix B) [28]. LMICs
can be divided into LICs and middle-income countries
(MICs), while MICs can be further divided into lower-
middle-income countries (LMCs) and upper-middle-
income countries (UMCs). All search terms included
MeSH terms/subject headings.
Types of studies and participants
Studies reporting data on measures of the association or
relationship between substances and SIB in LMICs were
included in this review. We included cross-sectional
studies, cohort studies, case-control studies, interrupted-
time series studies, before-and-after studies, ecological
studies and economic studies. Case report and case
series studies were excluded. All included studies had to
report quantitative data for bivariate or multivariate ana-
lyses that tested the association or relationship between
substance use and SIB. All studies that reported descrip-
tive statistics only were not included in this review. In
cases where a study reported both qualitative and quan-
titative findings, only the quantitative findings were
reported.
Identification of studies
EB and DG conducted the literature search. A total of
2237 articles were identified of which 647 were removed
as duplicates (Fig. 1). After testing agreement on 30 arti-
cles, EB and DG independently reviewed the titles and
abstracts of 1593 articles to identify those articles that
reported findings for an association or relationship be-
tween substance use and SIB. The two authors did not
discuss any of the articles during this screening process.
Once compared, discrepancies were discussed until
agreement was reached. If agreement could not be
reached, JB was consulted. This process yielded a total
of 414 articles that met the initial screening criteria.
Two authors independently screened the full-text of 414
articles against the inclusion and exclusion criteria, leav-
ing 108 studies included in the systematic review. The
literature search and screening process was managed
using Zotero.
Data extraction and management
Data were extracted from the 108 included studies. The
data that were extracted included: (a) study characteris-
tics (author; year; country; region; data collection start
and end dates; rural/urban; study setting, aim and de-
sign; sample size; population age, gender and ethnicity);
(b) substance use dimensions; (c) SIB dimensions; and
(d) association/relationship between substances and SIB
(odds ratios and 95% confidence intervals). The data
extraction was checked by EB for potential missing
data, errors and statistical accuracy. We contacted au-
thors in cases where data was not reported or informa-
tion was unclear. Data extraction and presentation of
the tables included in this systematic review was guided
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by other systematic reviews that focused on poverty in
LMICs [29, 30].
Assessment of methodological quality
Quality and appropriateness of the included studies
were assessed by DG and EB. A set of predetermined
criteria derived from the Scottish Intercollegiate Guide-
lines Network checklist was used to assess the meth-
odological quality and appropriateness of the studies
included in this review (Additional file 1: Table S1 and
Table S2) [31]. Due to the large number of articles, time
constraints, and limited resources, it was not possible
for quality checking of all articles to be done
independently by two authors. Quality checking of in-
cluded studies was completed in three phases to ensure
a high level of agreement between the authors. In the
first phase, a baseline of 20 articles was independently
quality checked by DG and EB. During quality check-
ing, the authors did not discuss any of the articles.
Once quality checking of the 20 articles was completed
and compared, discrepancies were discussed until
agreement was reached. If agreement could not be
reached, JB was consulted. In the second phase, a fur-
ther baseline of 20 articles was independently checked
and compared after quality checking was completed.
Discrepancies were discussed. In the third phase, the
Records identified through searching databases: (N = 2 237)
CINAHL (N=111); PubMED (N=563); DARE (N=7); 
PsychINFO (N= 616); Web of Science (N= 940)
Duplicate records removed (N=647)
Records after duplicates removed and double screened by title/abstract: (N= 1593)
Records excluded after initial screening of 
titles/abstracts (N= 1179)
Full-text articles double screened for eligibility (N= 414)
Language other than English (N=59)
Studies did not meet inclusion criteria for substances (N= 17)
Studies did not meet inclusion criteria for suicidal ideation 
and behaviour (N= 8)
No bivariate or multivariate analysis (N= 56)
Studies took place in high-income countries (N= 35)
Studies did not meet the study design criteria (N= 46)
No association between substances and suicidal ideation or
and behaviour (N= 85)
Records included (N= 108)
Records identified from 
searching references of 
reviews (N= 3)
Fig. 1 Flow chart of study search and selection process
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remaining articles were independently quality checked
by DG (n = 34) and EB (n = 34).
Data analysis
In order to avoid bias related to the results of a single
study that may be published in multiple publications,
the unit of analysis was the study rather than the publi-
cation. The included studies were stratified according to
substance type, substance use dimension (i.e. intoxica-
tion, use, pathological use), SIB dimension, and bivariate
or multivariate method of statistical analysis.
In organising the data, we differentiated between stud-
ies that specified a particular substance (e.g. alcohol) and
studies where the substance investigated was unspeci-
fied. We arranged the studies according to the different
classes of substances identified in DSM-5 [27]. It is im-
portant to note that there have been significant changes
between the DSM-IV and DSM-5 with regard to the ter-
minology and classification used for substance related
problems. The DSM-5 does not distinguish the diagno-
ses of substance abuse and dependence as in the DSM-
IV. Instead, the DSM-5 offers diagnostic criteria for
substance use disorder, including criteria for intoxica-
tion, withdrawal, substance/medication-induced disor-
ders, and unspecified substance-induced disorders. A
key consideration is that a proportion of studies in-
cluded in this systematic review were based on the
terminology used in the DSM-IV and therefore used
terms such as dependence and abuse. This also makes
it difficult to integrate or compare studies that use
DSM-IV conceptualisations with those that employ
DSM-5 concepts.
In this systematic review, substance use dimensions
were organised according to intoxication (i.e. drunken-
ness or use at the time of SIB), use (i.e. any past or
present use) and pathological use. The term ‘patho-
logical’ is used here to collectively refer to substance
misuse, abuse, addiction, dependence and substance use
disorder. The collective term ‘pathological substance
use’ was necessary, as the inconsistency in measures of
substance use and lack of description used between
studies made it difficult to meaningfully distinguish be-
tween misuse, abuse, addiction, dependence, and sub-
stance use disorder.
We included data for positive, negative, null and un-
clear associations between substance use dimensions
and SIB. The results for bivariate and multivariate statis-
tical analysis were reported separately in the tables and
supplementary material so that we could highlight other
influencing factors that were controlled for in multivari-
ate studies. Given the heterogeneity of (a) study designs,
(b) measures used to measure independent and
dependent variables and (c) analysis strategies, it was not
possible to conduct a meta-analysis.
Results
Overview of the studies
The characteristics of the 108 included articles are de-
scribed in Table 1, while detail is reported in Additional
file 1: Table S3 and Appendix C. With regards to study
region, 28 studies were from East Asia and Pacific (EAP)
, 20 from Europe and Central Asia (ECA), 18 from Latin
America and the Caribbean (LAC), 18 from Sub-Saharan
Africa (SSA), 12 from Middle East and North Africa
(MNA), ten from South Asia (SAS) and two studies from
multiple regions.
Of the 108 included studies, 68 (63%) were assessed
as high-quality and 23 (21%) were acceptable-quality
(Additional file 1: Table S2). Seventeen (16%) were con-
sidered low-quality due to issues related to selection
bias, attrition, the validity and reliability of exposure
measures and whether or not confounding factors were
accounted for.
The following substances were investigated: alcohol (n
= 70), tobacco (n = 40), cannabis (n = 10), cannabis and
mandrax (consumed together) (n = 1), opioids (n = 5),
sedatives (n = 6), stimulants (n = 4), unspecified prescrip-
tion medication (n = 3), inhalants (n = 2), and hallucino-
gens (n = 2). Fifty-two studies did not specify the type of
substance investigated.
Table 2 presents a summary of all studies by substance
type, substance use dimension, SIB dimension, and assess-
ment for study quality. Tables 3 and 4 summarise all associ-
ations between substance use and SIB. The majority of the
associations were positive when using bivariate (n = 136)
and multivariate (n = 105) analysis, indicating that sub-
stance use was consistently associated with SIB. Fewer as-
sociations were null when using bivariate (n = 56) or
multivariate (n = 49) analysis, indicating no significant asso-
ciation. Almost half (n = 22) of the null multivariate results
were positive in bivariate analysis. Two studies reported
negative associations (between non-fatal suicidal behaviour,
and alcohol use and cannabis use, respectively) using multi-
variate analysis. Thirteen of the associations were unclear.
Separate consideration of each substance use dimension
demonstrated substantial variation among associations.
We present a full account of the associations between
SIB and substance use below by presenting the data for
each type of substance and substance use dimension. In
cases where only one or two studies investigated a sub-
stance use dimension, the results are elaborated. In cases
where three or more studies investigated a substance use
dimension, only negative, unclear, or null results that are
of interest for the discussion are highlighted.
Alcohol intoxication
Ten studies investigated the association between alcohol
intoxication and SIB. Six studies found a positive associ-
ation between ever having been drunk and suicidal
Breet et al. BMC Public Health  (2018) 18:549 Page 5 of 18
ideation, while two reported a null association. In
Uganda, any drunkenness was associated with suicidal
ideation in bivariate but not in multivariate analysis [32].
Of the two studies exploring non-fatal suicidal behav-
iour, one study [33] found a positive association and one
study [34] found a null association. A study from Sri
Lanka showed a positive association between drinking
alcohol and suicide, only amongst the men in the sample
[35].
Half of the studies reporting on alcohol intoxication
and SIB focused on adolescents as their target popula-
tion [36–40] and yielded mixed results based on whether
or not the study controlled for comorbid illicit drug use.
For example, a population-based study among adoles-
cents between 11 and 15 years old reported a null asso-
ciation between getting drunk in the last month and
suicidal ideation after controlling for confounding fac-
tors that included unspecified illicit drug use [38]. In
contrast, a school-based study among adolescents be-
tween 14 and 16 years old reported a positive association
between having ever been drunk and suicidal ideation
even while controlling for age, sex, worry, loneliness,
Table 1 Sample characteristics
Characteristic Number
of
studies
Citations %
Study regiona
EAP 28 [33, 34, 36, 37, 41, 42, 45–54,
74, 87, 96, 98, 101, 103, 108,
109, 118, 119, 136, 137]
25.9
ECA 20 [60–62, 73, 75, 76, 80, 88, 89,
104, 106, 107, 111, 120, 121,
130, 138–141]
18.5
LAC 18 [38, 43, 44, 56–59, 72, 90, 93,
94, 102, 124–126, 142–144]
16.7
MNA 12 [39, 70, 71, 81, 95, 99, 105,
110, 112, 113, 122, 123]
11.1
SAS 10 [35, 63, 64, 77, 82, 91, 92, 100,
145, 146]
9.25
SSA 18 [32, 40, 65–69, 79, 83–86, 97,
114–117, 147]
16.7
Multiple study regions 2 [55, 78] 1.85
World Bank income groupb
LIC 5 [32, 79, 83, 92, 147] 4.63
LMC 19 [35, 40, 50, 52, 60, 63–65, 68,
69, 77, 81, 82, 88, 91, 100,
117, 130, 145]
17.6
UMC 80 [33, 34, 37–39, 41–45, 47–49,
51, 53, 54, 56–59, 61, 62, 66,
70–76, 79, 80, 84–87, 89, 90,
93–99, 101–116, 118–126,
136–144, 146]
74.1
Multiple income groups 4 [36, 46, 55, 78] 3.70
Location
Urban 18 [32, 34, 38, 52, 56, 58, 61, 63,
66, 88, 93, 96, 102, 115, 124,
130, 136, 145]
16.7
Peri-urban 1 [85] 0.93
Rural 4 [65, 68, 89, 109] 3.70
Both urban and rural 21 [36, 37, 42, 43, 46–48, 53, 54,
64, 77, 81, 87, 99, 105, 108,
114, 119, 137, 141, 147]
19.4
Multiple 3 [78, 86, 110] 2.78
Not available 61 [33, 35, 39–41, 44, 45, 49–51,
55, 57, 59, 60, 62, 67, 69–76,
79, 80, 82–84, 90–92, 94, 95,
97, 98, 100, 101, 103, 104,
106, 107, 111–113, 116–118,
120–123, 125, 126, 138–140,
142–144, 146]
56.5
Study setting
Clinic based 7 [49, 72, 74, 86, 101, 106, 126] 6.48
Community based 18 [37, 42, 46, 52, 56, 64, 70, 71,
78, 85, 87, 100, 109, 114, 117,
119, 143, 147]
16.7
Hospital based 34 [34, 35, 41, 43, 44, 47, 51, 57,
62, 65, 77, 84, 90, 94–96, 99,
104, 105, 110–113, 120, 121,
123, 125, 136, 138–142, 145]
31.5
Table 1 Sample characteristics (Continued)
Characteristic Number
of
studies
Citations %
School based 27 [33, 36, 39, 40, 45, 48, 50, 53–
55, 58–61, 63, 66–69, 80–83,
98, 103, 115, 116]
25
Others 22 [32, 38, 47, 73, 75, 76, 79, 88,
89, 91–93, 97, 102, 107, 108,
122, 124, 130, 137, 144, 145]
20.4
Substance (dimension)
Intoxication 7 [32, 33, 35, 36, 38–40] 6.5
Use 52 [32, 33, 36, 38–71, 79–86, 98,
101–103, 105–107]
48.2
Pathological use (i.e.,
Misuse, Abuse, Addiction,
Dependence, Disorder)
68 [34, 37, 41, 43–45, 50, 56, 60,
64–66, 70, 72–78, 83, 84, 86–
97, 99–101, 104, 108–126,
130, 136–140, 142–147]
63
Suicide (dimension group)
Suicidal ideation 43 [32, 33, 36–40, 45–48, 50, 52,
55, 56, 58–61, 63, 67–69, 74,
78, 79, 81, 83, 86–91, 95, 100,
105, 117, 122, 126, 143]
39.8
Nonfatal suicidal
behaviour
73 [33, 34, 42, 44, 46, 47, 50, 51,
53, 54, 56–60, 62–66, 70–72,
77, 78, 80–89, 93–99, 101–
104, 106, 107, 111–125, 136,
138, 139, 141–147]
67.6
Fatal suicide 11 [35, 41, 73, 75, 76, 108–110,
130, 137, 140]
10.2
aStudy regions: EAP East Asia and Pacific, ECA Europe and Central Asia, LAC
Latin America and the Caribbean, MNA Middle East and North Africa, SAS
South Asia, SSA Sub-Saharan Africa. bWorld bank income group: LIC Low
income country, LMC Low-middle-income country, and UMC
Upper-middle-income country
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ever smoked cannabis, and feelings of sadness or hope-
lessness [40]. The three studies that did not control for
illicit drug use found a positive association between alco-
hol intoxication and suicidal ideation [36, 37, 39].
The studies are predominantly based in the EAP region
(i.e. Thailand, China, Philippines, Vietnam, and Taiwan)
and are widely spread across study regions for EAP [33,
34, 36, 37, 41] and the SSA region (i.e. Zambia and
Uganda) [32, 40]. Individual studies were conducted in the
MNA (i.e. Lebanon) [39] and LAC (i.e. Brazil) [38]
regions, while no studies were from the ECA region.
Alcohol use
Thirty-three studies investigated the association between
alcohol use and SIB. Seventeen studies found a positive
association between ever having consumed or used alco-
hol and suicidal ideation, and two studies reported a null
association. Among the 23 studies that focused on non-
Table 2 Number of Studies by Substance type Specified Dimension, Suicide Dimension, and low-quality status
Substance Substance use dimension Suicidal Ideation NFSB Fatal suicide
Alcohol Intoxication 7 2 2
Use 18 (4 low-quality) 23 (4 low-quality) 0
Pathological use 11 28 (2 low-quality) 7 (2 low-quality)
Tobacco Intoxication 0 0 0
Use 18 (4 low-quality) 22 (3 low-quality) 0
Pathological use 8 (2 low-quality) 10 (1 low-quality) 0
Cannabis Intoxication 0 0 0
Use 5 (2 low-quality) 6 (1 low-quality) 0
Pathological use 1 2 0
Cannabis and Mandrax Intoxication 0 0 0
Use 0 1 0
Pathological use 0 0 0
Opioid Intoxication 0 0 0
Use 1 4 0
Pathological use 0 1 0
Sedatives Intoxication 0 0 0
Use 3 (1 low-quality) 4 (1 low-quality) 0
Pathological use 1 1 0
Stimulants Intoxication 0 0 0
Use 0 4 0
Pathological use 0 0 0
Unspecified prescription medication Intoxication 0 0 0
Use 2 2 0
Pathological use 0 0 0
Stimulants Intoxication 0 0 0
Use 0 4 0
Pathological use 0 0 0
Inhalants Intoxication 0 0 0
Use 0 1 0
Pathological use 1 1 0
Hallucinogens Intoxication 0 0 0
Intoxication 0 2 0
Use 0 0 0
Unspecified substance Intoxication 0 1 0
Use 15 (2 low-quality) 11 (3 low-quality) 0
Pathological use 10 (1 low-quality) 30 (8 low-quality) 4
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Table 3 Associations by Substance type Specified Dimension, Suicide Dimension, and Method of Statistical Analysis
Substance use dimension Suicide
dimension
Analysis Association between substances and suicide
Positive Negative Null Unclear Total
Alcohol
Alcohol intoxication
(n =10)
Suicidal ideation Bivariate 4 [32, 33, 39, 40] 0 0 0 4
Multivariate 4 [36, 37, 39, 40] 0 2 [32, 38] 0 6
Non-fatal suicidal
behaviour
Bivariate 1 [33] 0 1 [34] 0 2
Fatal suicide Bivariate 1 [35] 0 0 0 1
Multivariate 1 [35] 0 2 [35, 41] 1 [35] 4
Alcohol use (n = 33) Suicidal ideation Bivariate 11 [33, 46, 49, 50, 55,
56, 60, 61, 67, 69, 143]
0 2 [56, 68] 0 13
Multivariate 9 [36, 38, 45, 48, 50,
52, 56, 63, 67]
0 2 [56, 68] 0 11
Non-fatal suicidal
behaviour
Bivariate 12 [33, 42, 46, 50, 51,
53, 54, 56, 59, 60, 62, 70]
0 3 [44, 46, 71] 0 15
Multivariate 8 [43, 47, 50, 57, 58, 63–65] 1 [54] 3 [56, 57, 66] 0 12
Pathological alcohol use
(n = 37)
Suicidal ideation Bivariate 5 [56, 83, 87, 90, 143] 0 2 [89, 92] 0 7
Multivariate 7 [74, 78, 86, 88, 124, 143] 0 3 [56, 83, 100] 0 10
Non-fatal suicidal
behaviour
Bivariate 18 [56, 72, 78, 83, 87, 89,
94–97, 118, 136, 139,
141–145]
0 9 [72, 84, 89, 94,
96, 118, 141,
145, 147]
0 27
Pathological alcohol use
(n = 37)
Non-fatal suicidal
behaviour
Multivariate 11 [66, 78, 86, 88, 89, 93,
94, 124, 136, 138, 143]
0 7 [56, 78, 83, 94,
97, 100, 124]
0 18
Fatal suicide Bivariate 5 [37, 73, 75, 76, 140] 0 0 0 5
Multivariate 2 [130, 137] 0 0 0 2
Tobacco
Tobacco use (n = 29) Suicidal ideation Bivariate 10 [46, 49, 50, 55, 56, 59,
67, 69, 81, 83]
0 3 [46, 61, 68] 0 13
Multivariate 4 [36, 45, 56, 58] 0 5 [38, 50, 68,
83, 86]
2 [50, 79] 13
Non-fatal suicidal
behaviour
Bivariate 13 [33, 36, 46, 50, 53, 54,
56, 59, 67, 70, 80, 81, 83]
0 5 [46, 51, 53,
71, 84]
0 18
Multivariate 3 [56, 64, 82] 0 5 [58, 64, 83,
85, 86]
1 [50] 9
Pathological tobacco use
(n = 13)
Suicidal ideation Bivariate 4 [56, 87, 89, 90] 0 1 [92] 1 [60] 6
Multivariate 3 [56, 88, 91] 0 1 [88] 0 4
Non-fatal suicidal
behaviour
Bivariate 6 [56, 70, 87, 89, 94, 95] 0 3 [60, 89, 96] 0 9
Multivariate 4 [56, 88, 89, 93] 0 1 [94] 0 5
Cannabis
Cannabis use (n = 8) Suicidal ideation Bivariate 3 [40, 50, 60] 1 [59] 1 [69] 5
Non-fatal suicidal
behaviour
Bivariate 2 [50, 60] 0 2 [59, 70] 0 4
Multivariate 1 [66] 1 [57] 1 [57] 0 3
Cannabis
Pathological cannabis use
(n = 2)
Suicidal ideation Bivariate 0 0 1 [89] 0 1
Non-fatal suicidal
behaviour
Bivariate 2 [89, 97] 0 1 [89] 0 3
Multivariate 1 [97] 0 0 0 1
Cannabis and Mandrax (smoked together)
Cannabis and Mandrax
(smoked together) use
(n = 1)
Non-fatal suicidal
behaviour
Multivariate 1 [66] 0 0 0 1
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fatal suicidal behaviour, 20 reported a positive associ-
ation and six reported a null association. A Chinese
study reported that drinking alcohol before self-harm
was positively associated with severity of self-harm in bi-
variate analysis, yet was inversely related to the severity
of the self-harm when using multivariate analysis [42].
Thirty-one of the studies included in this sub-section
also included adolescents in their sample, while only two
studies focused solely on adults in their sample [43, 44].
The thirty-three studies that form part of this section
represent all of the study regions within LMICs but are
polarized to only some countries within these regions;
EAP (i.e. Philippines, China, Malaysia, Vietnam, Taiwan,
Thailand, Kiribati, Samoa, Solomon Islands, Vanuatu) [33,
Table 3 Associations by Substance type Specified Dimension, Suicide Dimension, and Method of Statistical Analysis (Continued)
Substance use dimension Suicide
dimension
Analysis Association between substances and suicide
Positive Negative Null Unclear Total
Opioid
Opioid use (n = 4) Suicidal ideation Multivariate 1 [98] 0 0 0 1
Non-fatal suicidal
behaviour
Bivariate 0 0 2 [70, 71] 0 2
Multivariate 2 [66, 98] 0 0 0 2
Pathological opioid use
(n = 1)
Non-fatal suicidal
behaviour
Multivariate 1 [99] 0 0 0 1
Sedatives
Sedative use (n = 5) Suicidal ideation Bivariate 0 0 0 1 [60] 1
Multivariate 2 [52, 98] 0 0 0 2
Non-fatal suicidal
behaviour
Bivariate 1 [60] 0 1 [100] 0 2
Multivariate 2 [66, 98] 0 0 0 2
Pathological sedative use
(n = 1)
Suicidal ideation Bivariate 1 [89] 0 0 0 1
Multivariate 1 [89] 0 0 0 1
Non-fatal suicidal
behaviour
Bivariate 1 [89] 0 0 0 1
Multivariate 1 [89] 0 0 0 1
Stimulants
Stimulant use (n = 4) Non-fatal suicidal
behaviour
Bivariate 0 0 1 [70] 0 1
Multivariate 3 [66, 101, 102] 0 0 0 3
Unspecified prescription medication
Use of unspecified prescription
medication (n = 3)
Suicidal ideation Multivariate 2 [52, 103] 0 0 0 2
Non-fatal suicidal
behaviour
Multivariate 2 [66, 103] 0 0 0 2
Inhalants
Inhalants use (n = 1) Non-fatal suicidal
behaviour
Multivariate 1 [66] 0 0 0 1
Pathological inhalant use (n = 1) Suicidal ideation Bivariate 0 0 1 [89] 0 1
Non-fatal suicidal
behaviour
Bivariate 1 [89] 0 1 [89] 0 2
Multivariate 1 [89] 0 0 0 0
Hallucinogens
Hallucinogens use (n = 2) Non-fatal suicidal
behaviour
Bivariate 1 [66] 0 1 [70] 0 2
Total Suicidal ideation Bivariate 38 0 11 3 52
Multivariate 33 0 13 2 48
Non-fatal suicidal
behaviour
Bivariate 58 0 30 0 88
Multivariate 42 2 17 1 62
Fatal suicide Bivariate 6 0 0 0 6
Multivariate 3 0 2 1 6
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36, 42, 45–55], LAC (i.e. Mexico, Peru, Brazil) [38, 43, 44,
56–59], ECA (i.e. Kosovo, Turkey) [60–62], SAS (i.e. India)
[63, 64], SSA (i.e. Kenya, Namibia, South Africa, Swaziland,
Uganda, Zambia, Zimbabwe) [55, 65–69], and MNA (i.e.
Iran) [70, 71]. Only two of the studies reporting on the as-
sociation between alcohol use and SIB made use of a case-
control study design [43, 51]. Most of the thirty-three stud-
ies were assessed to be of high or acceptable-quality. Eight
studies were assessed to be of low-quality [44, 47, 49, 51,
60, 62, 68, 69]. The studies assessed as low-quality were
from the ECA, EAP, LAC, and SSA study regions.
Pathological alcohol use
Thirty-seven studies investigated the association be-
tween pathological alcohol use and SIB. Of the studies
focusing on suicidal ideation, 10 reported a positive as-
sociation and five reported a null association. Twenty-
three studies found a positive association with non-fatal
suicidal behaviour and 15 studies reported a null associ-
ation. All seven studies focusing on suicide showed posi-
tive associations.
Of the thirty-seven studies included in this sub-section,
three studies made use of a case-control study design of
which one study was assessed to be of low-quality
[72], one acceptable-quality [73], and one high-quality
[74]. A further two studies made use of an inter-
rupted time-series design where both were assessed to
be of low-quality [75, 76]. One other study using a
cross-sectional study design was also assessed to be
of low-quality [77].
The studies that investigated the association between
pathological alcohol use and SIB varied with regard to
study region and country. Only one study [78] compared
study settings across all study regions by including at
least one country from each study region; Brazil (LAC),
Bulgaria (ECA), Colombia (LAC), India (SAS), Lebanon
(MNA), Mexico LAC, Nigeria (SSA), China (EAP),
Romania (ECA), South Africa (SSA), and Ukraine
(ECA). Specifically, this study included only adults aged
18 years and older and made use of a cross-sectional
study design that was assessed to be of acceptable-
quality.
Tobacco use
Twenty-nine studies explored the association between
tobacco use and SIB. Thirteen studies reported a positive
Table 4 Associations by Unspecified Substance Use Dimension, Suicide Dimension, and Method of Statistical Analysis
Substance use
dimension
Suicide
dimension
Analysis Association between substances and suicide
Positive Negative Null Unclear Total
Substance intoxication (n = 1) Non-fatal suicidal
behaviour
Bivariate 1 [104] 0 0 0 1
Substance use (n = 19) Suicidal ideation Bivariate 8 [39, 50, 55, 56,
61, 81, 83, 105]
0 1 [105] 3 [50, 55, 60] 12
Multivariate 7 [36, 38, 39, 47,
50, 67, 83]
0 4 [32, 56, 58, 67] 1 [50] 12
Non-fatal suicidal
behaviour
Bivariate 7 [33, 50, 56, 81,
83, 106]
0 2 [44, 60] 1 [50] 10
Multivariate 4 [47, 50, 58, 83] 0 2 [56, 83] 1 [51] 7
Pathological substance use (n = 37) Suicidal ideation Bivariate 2 [56, 115] 0 1 [92] 0 3
Multivariate 7 [78, 91, 117, 122,
124, 126, 143]
0 2 [56, 124] 0 9
Non-fatal suicidal
behaviour
Bivariate 15 [34, 56, 72, 77,
78, 94, 96, 104, 111–
113, 116, 117,
120, 121]
0 9 [44, 51, 72, 84,
96, 118, 123,
125, 141]
0 24
Multivariate 8 [56, 65, 78, 96, 117,
119, 122, 126]
0 9 [43, 45, 56, 94,
124, 143]
0 17
Fatal suicide Bivariate 1 [109] 0 2 [41, 110] 0 3
Multivariate 1 [108] 0 0 0 1
Total Suicidal ideation Bivariate 10 0 2 3 15
Multivariate 14 0 6 1 21
Non-fatal suicidal
behaviour
Bivariate 23 0 11 1 35
Multivariate 12 0 11 1 24
Fatal suicide Bivariate 1 0 2 0 3
Multivariate 1 0 0 0 1
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association between tobacco use and suicidal ideation,
seven reported a null association, and two reported un-
clear associations. In Botswana, tobacco smoking initi-
ation at younger than 14 years old was associated with
suicidal ideation in the past 12 months among girls but
not boys [79]. In Kiribati, Samoa, Solomon Islands, and
Vanuatu, tobacco smoking initiation younger than
12 years old was associated with both suicidal ideation
and non-fatal suicidal behaviour, while tobacco smoking
initiation at 12 years and older was not [50]. Thirteen
studies reported a positive association between tobacco
use and non-fatal suicidal behaviour, and ten studies re-
ported a null association. Two studies [50, 79] reported
an unclear association.
Eighteen studies investigating the association between
tobacco use and SIB included only adolescents (i.e. 11 to
18 years old) in their sample [36, 38, 45, 50, 54–56, 58, 59,
61, 67–69, 79–83]. The studies in this sub-section pre-
dominantly made use of a cross-sectional research design
with the exception of one case-control study that was
assessed to be of low-quality [51]. A further five studies
were assessed to be of low-quality [49, 51, 68, 69, 82, 84].
The twenty-eight studies were mostly conducted in the
EAP [33, 36, 45, 46, 49–51, 53–55] and SSA [67–69, 79,
83–86] study regions, while smaller groups of studies were
from the ECA [61, 80], LAC [38, 56, 58, 59], MNA [70,
71, 81], and SAS [64, 82] study regions.
Pathological tobacco use
Thirteen studies explored associations between patho-
logical tobacco use and SIB. Six studies [56, 87–91] re-
ported a positive association with suicidal ideation and
two studies [88, 92] reported a null association. One
study from Kosovo reported unclear findings, as daily
smoking was associated with suicidal ideation among
males but not females [60]. Eight studies [56, 70, 87–89,
93–95] reported a positive association with non-fatal
suicidal behaviour, while four studies [60, 89, 94, 96] re-
ported a null association.
Most studies were cross-sectional studies [56, 60, 70,
87–93, 95], two were cohort studies [94, 96], and none
were case-control or interrupted-time series studies. Only
two studies were assessed to be of low-quality [60, 91].
The study regions include EAP [87, 96], ECA [60, 88, 89],
LAC [56, 90, 93, 94], MNA [70, 95], and SAS [91, 92],
while no studies were from the SSA study region.
Cannabis use
Eight studies explored the association between cannabis
use and SIB. Two studies [50, 60] reported a positive as-
sociation between cannabis use and suicidal ideation,
and two [59, 70] reported a null association. The results
of a Zimbabwean study were unclear: cannabis smoking
in the past 12 months was associated with suicidal
ideation among the total sample and males, but not fe-
males [69].
Of the six studies focusing on non-fatal suicidal behav-
iour, two [50, 60] reported a positive association and two
[59, 70] reported a null association when using bivariate
analysis. When using multivariate analysis, results were
mixed. In South Africa, past month frequency of cannabis
use was associated with a higher composite measure of
suicide risk [66]. In Mexico, intake of cannabis prior to a
suicide attempt was inversely associated with an impulsive
or premeditated suicide attempt, while past cannabis use
was not associated with any suicide attempt [57].
Seven of the studies on the association between canna-
bis use and SIB included only adolescents between the
ages of 13 and 18 years old, while the remaining two
studies included both adolescents and adults in their
sample [57, 70]. The studies were predominantly cross-
sectional in nature, while one study was a cohort study
[57] and none were case-control or interrupted-time
series studies. The studies included in this sub-section
were from the EAP [50], ECA [60, 61], LAC [57, 59],
MNA [70], and SSA [40, 66, 69] study region while no
studies were from the SAS study region. Two of the nine
studies were assessed to be of low-quality [60, 69].
Pathological cannabis use
Two studies [89, 97] reported the association between
pathological cannabis use and SIB; both explored non-
fatal suicidal behaviour and one [89] explored suicidal
ideation. In Turkey, cannabis abuse showed a null asso-
ciation with suicidal ideation and suicide attempt, but a
positive association with self-harm [89]. A South African
study reported a positive association between cannabis
use/abuse/dependence and suicide attempts [97]. One
study included individuals between the ages of 16 and
22 years [89], while the other study included only adults
aged 18 years and older [97]. Both studies were assessed
to be of high-quality and made use of a cross-sectional
study design.
Cannabis and mandrax use (consumed together)
One study [66] explored the association between canna-
bis and mandrax use and SIB. This South African study
reported an association between past month frequency
of cannabis and mandrax use and higher suicide risk
among males from the age of 15 to 18 years old. This
study was assessed to be of high-quality and made use of
a cross-sectional study design.
Opioid use
Four studies investigated the association between opioid
use and SIB; one [98] focused on suicidal ideation and all
four [66, 70, 71, 98] focused on non-fatal suicidal behav-
iour. In China, lifetime, past year, and past month non-
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medical use of opioids was associated with suicidal idea-
tion, self-harm, and suicide attempt [98]. In Iran, opioid
use was not associated with lifetime suicide attempts [71].
In South Africa, higher past month frequency of opiate
use was associated with higher suicide risk [66].
Two studies included males and females between the
ages of 12 and 19 years old, while the remaining two
studies included individuals from the age of 14 years and
older. All four studies in this sub-section made use of a
cross-sectional study design and were of a high-quality.
The study regions included in this sub-section were
MNA [70, 71], SSA [66], and EAP [98], while no studies
were from the ECA, LAC, and SAS study regions.
Pathological opioid use
Only one study [99], from Iran (i.e. MNA study region),
explored the association between pathological opioid use
and SIB among males and females from the age of 16 to
25 years old. Specifically, the study focused on non-fatal
suicidal behaviour: opium dependence was associated with
self-immolation. The study was assessed to be of a high-
quality and made use of a case-control study design.
Sedative use
Five studies investigated the association between sedative
use and SIB; three [52, 60, 98] focused on suicidal ideation
and four [60, 66, 98, 100] focused on non-fatal suicidal be-
haviour. In Kosovo, tranquilizer use was associated with
suicidal ideation for females but not for males, making the
association for the overall sample unclear [60]. In China,
lifetime, past year, and past month non-medical use of
sedatives were associated with self-harm [98].
Three studies included only adolescents in their sam-
ple, while one study included individuals between 14
and 65 years old [52], and another included individuals
15 years and older [100]. All five studies employed a
cross-sectional study design, where four studies were
assessed to be of high-quality and one of low-quality
[60]. The study regions in this sub-section included EAP
[52, 98], ECA [60], MNA [100], and SSA [66], while no
studies were from the LAC or SAS study regions.
Pathological sedative use
Only one study [89] explored the association between
pathological sedative use and SIB, focusing on suicidal
ideation and non-fatal suicidal behaviour. This Turkish
study showed that tranquilizer abuse was positively asso-
ciated with suicidal ideation, self-harm and suicide at-
tempt. The individuals included in this sample were
between 16 and 22 years old. The study made use of a
cross-sectional study design and was assessed to be of
high-quality.
Stimulant use
Four studies investigated the association between stimu-
lant use and SIB. In China, past suicidal behaviour was
positively associated with amphetamine-type stimulant
(ATS) use [101]. A study from Iran reported a null asso-
ciation between ATS use and suicide attempt [70]. In
Brazil, cocaine use was associated with suicide risk
[102]. In South Africa, higher past month frequency of
cocaine use was associated with suicide risk [66].
All four studies made use of a cross-sectional design
and were assessed to be of high-quality. The study re-
gions included EAP [101], LAC [102], MNA [70], and
SSA [66], while no studies were from the ECA or SAS
study regions.
Use of unspecified prescription medication
Three studies explored the association between non-
medical use of prescription medication and SIB; two [52,
103] focused on suicidal ideation and two [66, 103] fo-
cused on non-fatal suicidal behaviour. A Chinese study
reported positive associations between having ever con-
sidered suicidal behaviour or suicide attempts and non-
medical use of prescription pain relief medication [103].
In South Africa, higher past month frequency of over-
the-counter medication use was positively associated
with non-fatal suicidal behaviour [66]. In Vietnam, any
non-medical use of prescription pain relief medication
was positively associated with suicidal ideation [52].
All three studies made use of a cross-sectional design
and were assessed to be of high-quality. The studies
were conducted in the EAP [52, 103] and SSA [66] re-
gions. Two of the studies included only adolescents [66,
103], while one study included individuals of 14 years
and older [52].
Inhalant use
One study [66] explored the association between inhal-
ant use and SIB, focusing on non-fatal suicidal behav-
iour. In South Africa, higher past month frequency of
inhalant use was positively associated with higher suicide
risk. The sample included only males between the ages
of 15 and 18 years old. The study made use of a cross-
sectional design and was assessed to be of high-quality.
Pathological inhalant use
One study [89] explored the association between patho-
logical inhalant use and SIB, and focused on both suicidal
ideation and non-fatal suicidal behaviour. In Turkey, in-
halant abuse was positively associated with self-harm,
while a null association was found between inhalant abuse
and suicidal ideation and suicide attempt. The sample in-
cluded only males and females between the ages of 16 and
22 years old. The study made use of a cross-sectional de-
sign and was assessed to be of high-quality.
Breet et al. BMC Public Health  (2018) 18:549 Page 12 of 18
Hallucinogen use
Two studies [66, 70] explored the association between
hallucinogen use and SIB; both focused on non-fatal sui-
cidal behaviour. In Iran, a null association was found be-
tween hallucinogen use and suicide attempt [70]. In
South Africa, higher past month frequency of hallucino-
gen use was positively associated with higher suicide risk
[66]. One study focused only on adolescent males be-
tween 15 and 18 years old [66], while the other study in-
cluded males and females aged 14 years and older. Both
studies made use of a cross-sectional design and were
considered to be of high-quality.
Unspecified substance intoxication
One study [104] explored the association between in-
toxication with an unspecified substance and SIB, and
focused on non-fatal suicidal behaviour in a sample of
males. In Turkey, substance intoxication was positively
associated with self-harm [104]. The study made use of a
cross-sectional design and was considered to be of high-
quality.
Use of unspecified substances
Nineteen studies investigated the association between
unspecified substance use and SIB; 15 [32, 38, 39, 41, 47,
50, 55, 56, 58, 60, 61, 67, 81, 83, 105] focused on suicidal
ideation, 12 [33, 44, 47, 50, 56, 58, 60, 67, 81, 83, 106,
107] focused on non-fatal suicidal behaviours, and none
reported on suicide. Eleven studies [36, 38, 39, 47, 50,
55, 56, 61, 81, 83, 105] found a positive association be-
tween substance use and suicidal ideation, five [32, 56,
58, 67, 105] reported a null association, and three [36,
55, 60] reported unclear findings. A study from Kosovo
did not report findings for the total sample but did re-
port a positive association between use of drugs other
than cannabis (amphetamines, hallucinogens, or ecstasy)
and suicidal ideation for males but not for females [60].
A study that included samples from the Philippines,
China, and Namibia showed that lifetime unspecified
drug use was consistently associated with suicide plan
across both genders in the Philippines and Namibia, but
not China [55].
Ten studies [33, 47, 50, 56, 58, 67, 81, 83, 106, 107]
found a positive association between unspecified sub-
stance use and non-fatal suicidal behaviour, four [44, 56,
60, 83] reported a null association, and one [50] reported
an unclear finding. In Kiribati, Samoa, Solomon Islands,
and Vanuatu, substance initiation with one, two, or three
substances before 12 years old was not consistently asso-
ciated with suicidal ideation and suicide attempt [50].
Fifteen studies included adolescent or young adult
samples ranging from 11 to 24 years old [32, 33, 36, 38,
39, 50, 55, 56, 58, 60, 61, 67, 81, 83, 106]. Only one study
made use of a case-control design [106], no studies used
an interrupted-time series design, where the remaining
studies were cross-sectional or cohort studies. Three
studies were assessed to be of low-quality [44, 47, 60].
No studies in this sub-section were from the SAS study
region, while studies were from the ECA [60, 61, 106,
107], EAP [33, 36, 47, 50, 55], LAC [38, 44, 56, 58],
MNA [39, 81], and SSA [32, 55, 67, 83] regions.
Pathological use of unspecified substances
Forty-two studies explored the association between
pathological unspecified substance use and SIB. Nine
studies reported a positive association with suicidal idea-
tion and three reported a null association. Nineteen
studies reported a positive association with non-fatal sui-
cidal behaviour and 16 reported a null association. Two
studies [108, 109] reported a positive association with
suicide and two [41, 110] reported a null association.
Three studies made use of a case-control study design
[51, 72, 111], while no studies used an interrupted-time
series design. Nine studies were assessed to be of low-
quality [44, 51, 72, 77, 84, 91, 111–113]. The studies
were spread across all six study regions; SSA [43, 65,
114–117], EAP [34, 41, 45, 51, 109, 118, 119], ECA [104,
111, 120, 121] SAS [77, 91, 92], MNA [110, 112, 113,
122, 123], and LAC [44, 56, 72, 78, 94, 124–126].
Discussion
The results from this review demonstrate a consistent
positive association between SIB and substance use, sub-
stance intoxication, and pathological substance use in
studies that use bivariate analysis. These positive associa-
tions are somewhat attenuated in studies employing
multivariate analysis, but remain predominantly positive.
Of the 162 associations reported in the multivariate ana-
lysis studies, 55 were null or unclear and only two studies
showed negative associations. This pattern of predomin-
antly positive associations was consistent across all sub-
stances, substance use dimensions (i.e. intoxication, use,
and pathological use), and all SIB dimensions (i.e. suicidal
ideation, non-fatal suicidal behaviour, and suicide). These
findings support the assertion that substance use is an im-
portant risk factor for SIB in LMICs, and should be the
target of continued public health policy, research and clin-
ical attention in the effort to advance suicide prevention
and reduce the morbidity and mortality associated with
suicidal behaviour. A number of points from this review
deserve attention and may provide directions for future
research in this area.
First, it is significant that most of the included studies
focused on alcohol and tobacco (n = 78), while illicit drugs
and non-medical use of prescription medication received
comparatively less attention (n = 19). Notable here is the
absence of studies on substances such as methampheta-
mine (also known as Tik) and methcathinone (also known
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as Kat), which are used in LMICs [127, 128]. This bias in
the literature may in part reflect the difficulties researchers
face when trying to collect information on illegal activities.
Under-reporting of illicit drug use in LMICs is linked to
legal constrictions, limited resources and a lack of expert-
ise to screen for drug use [27]. Furthermore, the studies
included in this systematic review do not demonstrate the
different effects of various substances (e.g. alcohol com-
pared to different types of illicit drug use) as risk factors
for SIB. Future research could employ rigorous epidemio-
logical methods that might report on the public health
burden and potential mechanisms of the association be-
tween a range of substances, substance use dimensions,
and SIB. For example, a timeline follow-back methodology
may be used to identify potential mechanisms underlying
the association between different types of substances and
SIB. This information would be helpful to guide policy
makers on whether to concentrate their efforts on the re-
duction of alcohol, tobacco, illicit drug use, or a combin-
ation of substances.
Second, the bulk of the evidence comes from studies
conducted in UMCs (n = 80) and from EAP, ECA, LAC,
and SSA regions. This suggests that there is a relative
scarcity of studies from LMCs and LICs as well as from
regions such as SAS and MNA. This finding is signifi-
cant given that there are four LICs and one LMC found
among the top ten countries with the highest suicide
rates in the world. These findings may in part reflect the
fact that this review only included studies published in
English. Nonetheless, the apparent unequal distribution
of studies across LMICs warrants further attention.
Third, most of the literature in this field focuses on
suicidal ideation (n = 47) and non-fatal suicidal behav-
iour (n = 78); only 11 associations were reported between
substance use and suicide. Seven positive associations
were reported between alcohol and suicide, no associa-
tions were reported for illicit drug use and suicide, and
two associations were reported for unspecified substance
use and suicide. This suggests that there is a gap in the
literature focusing on the association between death by
suicide and substance use, particularly illicit drug use.
This may in part reflect the reality that in low resource
environments it is not routine practice to screen for
illicit drugs in mortuaries [127] and that many LMICs
lack mortality surveillance systems [1].
Fourth, 11 [35, 50, 55, 60, 68, 69, 76, 79, 95, 98, 106]
of the included studies reported findings for men and
women separately, while other studies combined them
into one group. Globally, evidence suggests that men are
at higher risk for substance use and that gender is an
important variable in the aetiology of suicidal behaviour
[1, 6, 11]. The specific role of gender in the association
between substance use and SIB is complex and has not
been adequately investigated in the reviewed literature.
Fifth, the majority of studies included in this review
were conducted within a risk factor paradigm and have
failed to advance the development of theory. This point
has been made by other authors in the context of studies
about poverty and SIB [129]. It might be helpful if subse-
quent studies moved beyond simply establishing that
substance use is a risk factor for SIB. In this context it is
also significant that most studies included in this review
employed statistical analyses that only reported on an
association between substance use and SIB, without tak-
ing potential confounding variables into account. Studies
using sophisticated statistical analyses were scarce. One
study [130] made use of structural equation modelling,
but did not investigate the specific mechanism of action
or how exactly substance use increases the risk for SIB.
Among studies included in this review, factors that
interacted with substance use and SIB were age [35],
level of education [38], socioeconomic status [58], feel-
ings of sadness or loneliness [40], parental physical
abuse or neglect [32], and comorbid psychiatric disorder
[56]. However, the nature of the interaction between
these factors is not clear from the available evidence at
this time. To answer questions about how substance use
interacts with other variables to precipitate SIB, it will
be necessary to conduct studies which employ more so-
phisticated statistical methods and modelling to investi-
gate the interaction between a wider array of variables.
Sixth, most included studies employed a cross-
sectional study design. The comparative lack of longitu-
dinal studies in this area is noteworthy. Longitudinal
studies could help illuminate how contextual and tem-
poral factors interact with substance use to precipitate
SIB. Longitudinal studies will also help generate know-
ledge on the cumulative effects of substance use over
time and how changes in patterns of use may influence
SIB. Specifically, studies might focus on factors such as:
the role of acute versus chronic substance use; patterns
and quantity of substance use; and frequency of sub-
stance use. Moreover, suicidal ideation is known to fluc-
tuate over the course of time (sometimes rapidly)
making it problematic to simply rely on results from
cross-sectional studies [131]. Longitudinal studies may
also assist us to understand the progression from sui-
cidal ideation to non-fatal suicidal behaviour and death
by suicide among persons who use substances. Such
knowledge could contribute to theory building in this
area. It is likely that resource constraints in LMICs im-
pede the completion of longitudinal studies in this field.
There are a number of reasons why it is difficult to
complete longitudinal research in low resource environ-
ments, including the high costs of this research, high
rates of attrition, and the fact that many people living in
low resource environments are highly mobile, making
follow-up difficult and expensive [132, 133].
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Study limitations
This systematic review represents an important first step
in synthesizing the current literature and planning future
public health research in this field. Nonetheless, this
study has some limitations. The data may be influenced
by publication bias, as studies that report negative or
null associations often go unpublished [134]. Some cau-
tion is necessary when interpreting the findings from
studies assessed as low-quality and where a sub-section
consists of only one or two studies (i.e. pathological can-
nabis use, cannabis and mandrax use, pathological opi-
oid use, pathological sedative use, inhalant use, and
hallucinogen use). Excluding qualitative studies limits
our ability to understand the mechanism by which sub-
stance use relates to SIB as well as the role of sociocul-
tural factors that influence this association. This review
only included studies published in English [135], and
was limited to studies published between 2006 and 2016.
Conclusions
The results from this review strongly support the asser-
tion that substance use is associated with increased risk
of SIB. This confirms the call from the WHO to focus
on substance use as a key element of suicide prevention
in LMICs. We assert that the current evidence has the
following public health implications in LMICs: (1) sub-
stance use is a potentially modifiable risk factor for fatal
and non-fatal suicidal behaviour; (2) assessment and
management of substance use should be integral to the
care of at-risk patients; (3) suicide prevention in LMICs
should focus on reducing consumption and hazardous
use of alcohol, tobacco, cannabis, opioids, sedatives,
stimulants and non-medical use of medications; and (4)
more focused research is required in order to better
understand the nature of the relationship between sub-
stance use and SIB across all types of substances, sub-
stance use dimensions, SIB dimensions, and spread
throughout all LMICs. It would be helpful if future re-
search focused on providing insight into the nature of
this association in a way that permits an understanding
of why substance use precipitates SIB among some indi-
viduals but not others. We suggest that research needs
to be theory-driven and needs to integrate qualitative
studies that explore the lived experience of substance
use among individuals who engage in SIB.
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